Katsuhiro Mori

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types

Yutaka Kanda, Tsuyoshi Yamada, Katsuhiro Mori et al. · Glycobiology · 2006 · 370 citations

Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA

Katsuhiro Mori, Reiko Kuni‐Kamochi, Naoko Yamane‐Ohnuki et al. · Biotechnology and Bioengineering · 2004 · 173 citations

Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC

Harue Imai-Nishiya, Katsuhiro Mori, Miho Inoue et al. · BMC Biotechnology · 2007 · 153 citations · Full text

Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: A new strategy for generating completely non-fucosylated recombinant therapeutics

Yutaka Kanda, Harue Imai-Nishiya, Reiko Kuni‐Kamochi et al. · Journal of Biotechnology · 2007 · 121 citations

Gdp-mannose 4,6-Dehydratase, Engineering, Biochemistry +10

Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils

Mami Shibata‐Koyama, Shigeru Iida, Hirofumi Misaka et al. · Experimental Hematology · 2009 · 114 citations

Inflammation, Immune Effector Functions, Microbial Pathogens +14